Common grade 3 or 4 adverse events included febrile neutropenia (61%), aspartate aminotransferase (AST)/alanine aminotransferase (ALT) elevation (13%), anemia (19%), and thrombocytopenia (26%). This evidence concerns the gene GPT and anemia.